Public research preview

Robert J. Wittman, Representative disclosure: AbbVie Inc. Common Stock (ABBV)

Disclosed a buy transaction in AbbVie Inc. Common Stock (ABBV). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
0/100
Signal Quality
63/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
8 Jul 2022, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
22 days

Timeline

Transaction date

16 Jun 2022

Public disclosure

8 Jul 2022

Now

Tracked today

Filing delay: 22 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
10 Jun 2026

Stock path

ABBV from pre-transaction context through latest close.

Bought

16 Jun 2022 · 120.298 USD · Not public yet

System decision

Would have boughtThe strategy would have bought this signal, but the entry window has closed. Simulated entry on 8 Jul 2022 at 132.141 USD. Since entry: +68.8%. Planned exit on 2 Sept 2022 after 40 trading days.

Window closed117.1177.9238.7USDDate16 Jun8 Jul8 JunOfficial disclosure8 JulPlanned exit132.1System buyBoughtDisclosureLatest
  • Not public yet
  • Buy window
  • Window closed
  • System buy
  • Planned exit
Observed transaction close
120.298
Observed disclosure close
132.141
Observed latest close
223.07
Pre-disclosure move
+9.8%
Post-disclosure move
+68.8%
Market-adjusted move
+68.8%
1w since disclosure
+1.4%
1m since disclosure
-7.3%
3m since disclosure
-7.4%
Pre-disclosure peak run-up
+10.8%
Retrace from peak
-0.8%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 8 Jul 2022, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerABBV
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20021344.pdf
personNameRobert J. Wittman
amountRange$1,001 - $15,000
companyNameAbbVie Inc. (ABBV)
publishedAt2022-07-08T00:00:00.000Z
rawDocumentIdraw-us-house-20021344-1
disclosureDate2022-07-08
transactionDate2022-06-16
transactionTypeP